Vaxil Bio Ltd. (TSXV:VXL)
Canada · Delayed Price · Currency is CAD 0.1450
0.00 (0.00%)
At close: Oct 7, 2026
Vaxil Bio Market Cap
Vaxil Bio has a market cap or net worth of CAD 577.68 thousand as of October 9, 2026. It is the 50,501st most valuable company in the world and the 2,608th biggest in Canada. Its market cap has increased by 13.98% in one year.
Market Cap
577.68K
Enterprise Value
113.68K
Revenue
n/a
Global Rank
Country Rank
#2,608 Canada
PE Ratio
1.33
ChartMarket Cap Chart
Since March 10, 2016, Vaxil Bio's market cap has increased from 97.36K to 577.68K, an increase of 493.37%. That is a compound annual growth rate of 18.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 577.68K | - |
| Dec 30, 2025 | 577.68K | -83.13% |
| Dec 29, 2023 | 3.42M | 25.00% |
| Dec 30, 2022 | 2.74M | -73.33% |
| Dec 31, 2021 | 10.27M | -70.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovotech | 3.54M |
| Quest PharmaTech | 3.38M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 1.59M |
| Universal Ibogaine | 1.56M |
| MindBio Therapeutics | 983.21K |
| Doseology Sciences | 961.40K |
| Waverley Pharma | 540.00K |